These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1122370)

  • 21. Decreased nigral neuromelanin in Alzheimer's disease.
    Reyes MG; Faraldi F; Rydman R; Wang CC
    Neurol Res; 2003 Mar; 25(2):179-82. PubMed ID: 12635519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pigmented olfactory neuroblastoma: a new example of melanotic neuroepithelial neoplasm.
    Curtis JL; Rubinstein LJ
    Cancer; 1982 May; 49(10):2136-43. PubMed ID: 7074529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
    Biesemeier A; Eibl O; Eswara S; Audinot JN; Wirtz T; Pezzoli G; Zucca FA; Zecca L; Schraermeyer U
    J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Striato-nigral degeneration. A propos of 2 anatomo-clinical cases].
    Michel D; Tommasi M; Laurent B; Trillet M; Schott B
    Rev Neurol (Paris); 1976 Jan; 132(1):3-22. PubMed ID: 968312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional effects of neuromelanin and synthetic melanin in model systems.
    Double KL
    J Neural Transm (Vienna); 2006 Jun; 113(6):751-6. PubMed ID: 16755379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors.
    Churchyard A; Donnan GA; Hughes A; Howells DW; Woodhouse D; Wong JY; Kalnins RM; Mendelsohn FA; Paxinos G
    Ann Neurol; 1993 Aug; 34(2):219-26. PubMed ID: 8338346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
    Fedorow H; Tribl F; Halliday G; Gerlach M; Riederer P; Double KL
    Prog Neurobiol; 2005 Feb; 75(2):109-24. PubMed ID: 15784302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Olivo-ponto-cerebellar and striato-nigral atrophy. 3 anatomo-clinical cases. Review of the literature].
    Kohler A
    Schweiz Arch Neurol Psychiatr (1985); 1986; 137(2):15-42. PubMed ID: 2422747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease.
    Nandhagopal R; Kuramoto L; Schulzer M; Mak E; Cragg J; McKenzie J; McCormick S; Ruth TJ; Sossi V; de la Fuente-Fernandez R; Stoessl AJ
    Brain; 2011 Nov; 134(Pt 11):3290-8. PubMed ID: 22075521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?
    Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL
    Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
    Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Striato-nigral degeneration. Apropos of a clinical, therapeutic, and anatomic study of 2 cases].
    Boudin G; Guillard A; Mikol J; Galle P
    Rev Neurol (Paris); 1976 Feb; 132(2):137-56. PubMed ID: 973069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Presence of aluminum and magnesium in the cerebral arteries and parenchyma of patients with striatonigral syndrome: study by Castaing's microprobe].
    Duckett S; Galle P; Escourolle R; Grey F
    C R Acad Hebd Seances Acad Sci D; 1976 Jun; 282(23):2115-7. PubMed ID: 822952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
    Ghorayeb I; Fernagut PO; Aubert I; Bezard E; Poewe W; Wenning GK; Tison F
    Mov Disord; 2000 May; 15(3):531-6. PubMed ID: 10830420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study.
    Shinotoh H; Inoue O; Hirayama K; Aotsuka A; Asahina M; Suhara T; Yamazaki T; Tateno Y
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):467-72. PubMed ID: 8505636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
    Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
    J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromelanin and Parkinson's disease.
    Marsden CD
    J Neural Transm Suppl; 1983; 19():121-41. PubMed ID: 6321645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of preclinical Parkinson's disease with PET.
    Brooks DJ
    Geriatrics; 1991 Aug; 46 Suppl 1():25-30. PubMed ID: 1909983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.
    Chung SJ; Lee Y; Lee JJ; Lee PH; Sohn YH
    Eur J Neurol; 2017 Oct; 24(10):1314-1319. PubMed ID: 28782870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.